Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Urology
|
July 9, 2002
Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction
Sherif Aboseif, Kirk Tamaddon, Stuart Chalfin, et al.
The Canadian Journal of Urology
|
February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral lift
Neal Shore, Sheldon Freedman, Steven Gange, et al.
Prostate Cancer and Prostatic Diseases
|
December 14, 2018
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study
Daniel Rukstalis, Douglas Grier, Sean P Stroup, et al.
Urology
|
April 10, 2004
Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia
Claus G Roehrborn, Leonard S Marks, Tom Fenter, et al.
World Journal of Urology
|
February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results
Neal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Journal of Endourology
|
May 23, 2019
Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study
Gregg Eure, Steven Gange, Peter Walter, et al.
The Journal of Sexual Medicine
|
January 20, 2025
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia
Olivia Copelan, Jared Moss, Sheldon Freedman, et al.
American Journal of Men'S Health
|
December 8, 2019
A Novel Video-Based Patient Education Program to Reduce Penile Prosthetic Surgery Cancellations
Eric Ballon-Landa, Raul Clavijo, Martin Gross, et al.
World Journal of Urology
|
January 31, 2018
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement
Neal Shore, Ronald Tutrone, Mitchell Efros, et al.
The Journal of Urology
|
August 9, 2023
Reply by Authors
Steven A Kaplan, Jared Moss, Sheldon Freedman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Urology
|
July 9, 2002
Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction
Sherif Aboseif, Kirk Tamaddon, Stuart Chalfin, et al.
The Canadian Journal of Urology
|
February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral lift
Neal Shore, Sheldon Freedman, Steven Gange, et al.
Prostate Cancer and Prostatic Diseases
|
December 14, 2018
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study
Daniel Rukstalis, Douglas Grier, Sean P Stroup, et al.
Urology
|
April 10, 2004
Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia
Claus G Roehrborn, Leonard S Marks, Tom Fenter, et al.
World Journal of Urology
|
February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results
Neal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Journal of Endourology
|
May 23, 2019
Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study
Gregg Eure, Steven Gange, Peter Walter, et al.
The Journal of Sexual Medicine
|
January 20, 2025
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia
Olivia Copelan, Jared Moss, Sheldon Freedman, et al.
American Journal of Men'S Health
|
December 8, 2019
A Novel Video-Based Patient Education Program to Reduce Penile Prosthetic Surgery Cancellations
Eric Ballon-Landa, Raul Clavijo, Martin Gross, et al.
World Journal of Urology
|
January 31, 2018
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement
Neal Shore, Ronald Tutrone, Mitchell Efros, et al.
The Journal of Urology
|
August 9, 2023
Reply by Authors
Steven A Kaplan, Jared Moss, Sheldon Freedman, et al.
Page
of 2